Pinnacle Research Group   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Anniston AL United States (1998)

Organization Overview

First Clinical Trial
2011
NCT01461369
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Pinnacle Clinical Research | Pinnacle Clinical Research, PLLC | Pinnacle Oncology Hematology | Pinnacle Research Group LLC, Anniston, AL 36207 | Pinnacle Trials, Inc

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 1)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Erythromelalgia (Phase 2)

Fatty Liver (Phase 2)

Fibrosis (Phase 2)

Influenza, Human (Phase 2)

Liver Cirrhosis (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 2)

Osteoarthritis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 11
  • # of Trial APIs: 10